Penn Medicine’s Gerard D. Schellenberg, PhD, a professor of Pathology and Laboratory Medicine and Li-San Wang, PhD, an associate professor of Pathology and Laboratory Medicine, along with investigators from Boston University, Case Western Reserve University, Columbia University, the University of Miami, and the University of Indiana have been awarded a $10.8 million grant from the National Institute on Aging (NIA) to launch their joint Coordinating Center for Genetics and Genomics of Alzheimer’s disease.
“This is an exciting opportunity to apply new technologies to improve our understanding of the biological pathways underlying this devastating disease,” said Dr. Schellenberg, quoted in a Penn Medicine News Release. “The new center will stimulate collaborations between hundreds of U.S. and international Alzheimer’s genetics researchers by aggregating and analyzing very large data sets and sharing the results. This type of global interaction is needed if we are to make progress in solving this devastating illness.”
Drs. Schellenberg and Wang are no strangers to the genetics and genomics of Alzheimer’s and related neurodegenerative diseases. This new grant is just one of the projects in their recently introduced Penn Neurodegeneration Genomics Center (PNGC) which they co-direct. Other projects include the Alzheimer’s Disease Genetics Consortium (ADGC), Alzheimer’s Disease Sequencing Project (ADSP), Consortium for Alzheimer’s Sequence Analysis (CASA), and NIA Genetics of Alzheimer’s Disease Data Storage Site (NIAGADS).